Eton Pharmaceuticals, Inc. (ETON)
67.41
+3.06
(+4.76%)
USD |
NASDAQ |
Nov 10, 16:00
67.41
0.00 (0.00%)
After-Hours: 16:42
Eton Pharmaceuticals Price to Book Value : 22.36 for Nov. 10, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 09, 2026 | 21.34 |
| November 06, 2026 | 18.72 |
| November 05, 2026 | 15.64 |
| November 04, 2026 | 16.82 |
| November 03, 2026 | 16.90 |
| November 02, 2026 | 16.85 |
| October 30, 2026 | 17.31 |
| October 29, 2026 | 17.80 |
| October 28, 2026 | 17.18 |
| October 27, 2026 | 16.97 |
| October 26, 2026 | 16.64 |
| October 23, 2026 | 16.58 |
| October 22, 2026 | 16.59 |
| October 21, 2026 | 16.35 |
| October 20, 2026 | 16.65 |
| October 19, 2026 | 16.32 |
| October 16, 2026 | 16.69 |
| October 15, 2026 | 17.02 |
| October 14, 2026 | 17.54 |
| October 13, 2026 | 17.69 |
| October 12, 2026 | 18.32 |
| October 09, 2026 | 18.31 |
| October 08, 2026 | 18.16 |
| October 07, 2026 | 18.20 |
| October 06, 2026 | 18.16 |
| Date | Value |
|---|---|
| October 05, 2026 | 18.45 |
| October 02, 2026 | 18.36 |
| October 01, 2026 | 17.24 |
| September 30, 2026 | 17.08 |
| September 29, 2026 | 35.94 |
| September 28, 2026 | 35.94 |
| September 25, 2026 | 35.03 |
| September 24, 2026 | 36.13 |
| September 23, 2026 | 33.77 |
| September 22, 2026 | 34.67 |
| September 21, 2026 | 33.59 |
| September 18, 2026 | 33.70 |
| September 17, 2026 | 34.66 |
| September 16, 2026 | 34.22 |
| September 15, 2026 | 33.36 |
| September 14, 2026 | 34.99 |
| September 11, 2026 | 34.66 |
| September 10, 2026 | 35.15 |
| September 09, 2026 | 35.73 |
| September 08, 2026 | 36.04 |
| September 04, 2026 | 35.50 |
| September 03, 2026 | 36.38 |
| September 02, 2026 | 37.63 |
| September 01, 2026 | 36.70 |
| August 31, 2026 | 36.70 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Aquestive Therapeutics, Inc. | -- |
| Pfizer Inc. | 1.880 |
| Elite Pharmaceuticals, Inc. | 2.433 |
| Daré Bioscience, Inc. | -- |
| Amneal Pharmaceuticals, Inc. | 206.83 |
Price to Book Value Related Metrics
| PE Ratio | 44.65 |
| PS Ratio | 15.39 |
| Price to Free Cash Flow | 108.60 |
| Price | 67.41 |
| Earnings Yield | 2.24% |
| Market Cap | 1.943B |
| Operating PE Ratio | 53.36 |
| Normalized PE Ratio | 44.65 |